Parabacteroides distasonis reduces Clostridioides difficile infection severity by alleviating gut dysbiosis and modulating secondary bile acids in mice.
- Open access
- 1 cites
Moving in Virulence.
Rebuilt
Parabacteroides distasonis reduces Clostridioides difficile infection severity by alleviating gut dysbiosis and modulating secondary bile acids in mice.
Newest first · last 60 days
Fecal microbiota transplantation shows potential to improve irritable bowel syndrome symptoms, with significant effects observed in some analyses but overall very low certainty evidence.
Consuming sugar-rich foods during antibiotic treatment worsens gut microbiome disruption, increasing Enterococcus expansion and reducing microbial diversity.
Clostridioides difficile produces over 28 unique N-acyl amino acids, including high levels of phenylacetic acid, distinguishing it from other gut bacteria.
A single Faecalibacterium prausnitzii EXL01 strain significantly reduces recurrent Clostridioides difficile infection in humans, with 83.3% remaining recurrence-free at 8 weeks.
C. difficile assembles a unique divisome complex in three phases, with PBP1 replacing FtsW-FtsI in septal peptidoglycan synthesis, highlighting a distinct bacterial division mechanism.
Multiple toxin-antitoxin systems in Helicobacter pylori enhance its adaptability, with at least 20 validated systems influencing persistence and pathogenicity.
Deoxycholate promotes Clostridioides difficile virulence by stimulating Escherichia coli to produce proline, boosting infection severity by 50-fold in co-infection models.
Bioengineering Escherichia coli Nissle 1917 with the ttr operon enables effective treatment of colitis by promoting colonization during inflammation, outperforming traditional therapies.
Journals this month
Moving areas, week to 3 Oct 2026